Industry News (Joint Venture)

Distribution and Marketing Agreement Entered in Japan

Published in TB and Outbreaks Week, June 14th, 1999

Visible Genetics Inc. (VGI), Toronto, Ontario, Canada, and Roche Diagnostics K.K. (RDKK) have entered into an agreement whereby RDKK is the exclusive distributor in Japan of VGI's GeneKits, including HIV-1, hepatitis C (HCV), and TB TruGene assays, and the distributor of their OpenGene automated DNA sequencing systems in the diagnostic market.

Contracted through blood transfusions, contaminated needles, and sexual contact, HCV is a growing threat in Japan, where more than 2.5 million Japanese suffer from this blood-borne viral infection. RDKK has marketing clearance from the Japan Ministry of Health for the Roche AMPLICOR HCV test and Version 2.0 AMPLICOR HCV MONITOR...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1999-06-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry